From Survivors to Advocates: Two Leaders are Pushing for Progress in Canada and Around the World
by Mara Klecker Natalie Richardson, of British Columbia, Canada, hasn’t forgotten the fear and uncertainty she felt after her…
Blog - Melanoma360
12/08/2021
From Survivors to Advocates: Two Leaders are Pushing for Progress in Canada and Around the World
by Mara Klecker Natalie Richardson, of British Columbia, Canada, hasn’t forgotten the fear and uncertainty she felt after her…
|
|
12/07/2021
In One Woman’s Memory, a Tradition Helps Create a Community of Support
by Mara Klecker The idea for a walk to raise funds and awareness for melanoma came to Tricia Edwards in…
|
|
12/07/2021
Shop Amazon Smile This Holiday Season
We continually try to answer the question that so many of you ask us: How can I help? Here…
|
12/04/2021
FDA Approves KEYTRUDA for Stage IIB and IIC Melanoma Patients
December 4, 2021 (Richmond, California) Yesterday, Merck announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda…
|
|
11/17/2021
THE GRATITUDE GALA: AIM’s 3rd Annual No Show Gala & Online Auction
What is a “no-show” gala? AIM at Melanoma’s Third Annual No Show Gala & Auction is a unique fundraiser that…
|
10/07/2021
Relatlimab/Nivolumab Application for Frontline Advanced Melanoma Validated by EMA
October 1, 2021 Kristi Rosa REPOST from OncLive The European Medicines Agency has validated its marketing authorization application for the…
|
|
09/27/2021
Vaccines 2021—Major Advances in Preventing Death from Infection and Malignancy
By Kim Margolin, M.D., FACP, FASCO Vaccine background and brief history The word “vaccine” comes from the Latin word vacca…
|
|
09/26/2021
Using Facebook For Good
One of the most common questions we are asked here at AIM by patients, families, and friends is How can…
|
09/24/2021
FDA Takes Steps Aimed at Improving Quality, Safety and Efficacy of Sunscreens
For Immediate Release: September 24, 2021 (repost from FDA) The U.S. Food and Drug Administration today took steps aimed at…
|
09/24/2021
International Survivor Spotlight: José Correia, Portugal
By Mara Klecker José Correia’s melanoma diagnosis was nearly a quarter-century ago, but he is committed to spreading awareness about…
|
|
Recent Posts
Apr. 10, 2026
FDA Does Not Approve RP1 in Combination with Nivolumab for Advanced Melanoma: What This Means for Patients
Apr. 07, 2026
2026 National Sunscreen Partner
Apr. 07, 2026
Young Adult Cancer & Mental Health
Apr. 02, 2026
Uveal Melanoma Webinar: Part II — Navigating Treatment in the Metastatic Setting
Mar. 26, 2026